Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033

Description

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

TB is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

The global tuberculosis diagnostics market was valued at $1,748.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%

Rise In The Adoption Of Nucleic Acid Testing

During the historic period, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market. A nucleic acid amplification test (NAAT) for tuberculosis (TB) is used to identify Mycobacterium tuberculosis complex (MTBC) DNA (deoxyribonucleic acid) in sputum or other respiratory samples. The nucleic acid testing provides benefits such as greater accuracy than conventional microscopy techniques and faster findings. For example, in 2022, according to data published by the State of Rhode Island Department of Health, it has been observed that Rhode Island State Health Laboratory (RISHL) utilizes the Cepheid Xpert MTB/RIF assay for NAAT, an automated molecular diagnostic test that is used to detect the presence of Mycobacterium tuberculosis complex (MTB-complex) DNA in respiratory specimens. Further, in February 2021, the World Health Organization (WHO) announced updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance. The updates on new technologies included moderate complexity automated Nucleic Acid Amplification Tests (NAATs), for detection of TB and resistance to rifampicin and isoniazid, low complexity automated NAATs for detection of resistance to isoniazid and second-line anti-TB agents and high complexity hybridization-based NAATs for detection of resistance to pyrazinamide. Therefore, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market.

Next Generation Sequencing (NGS) Platforms For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in April 2024, QIAGEN, a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world's leading infectious disease killer. The QIAseq xHYB Mycobacterium tuberculosis Panel represents a major advancement in solving the problem of bacterial WGS from complex host samples, using next-generation sequencing (NGS). Further, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company, introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

The global tuberculosis diagnostics market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 28.3% of the total market in 2023.

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by test type, by disease stage and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tuberculosis diagnostics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by test type, by disease stage and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
3) By End User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
Companies Mentioned: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMerieux SA.; Danaher Corporation (Cepheid, Inc.)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1333

1 Executive Summary

1.1 Tuberculosis Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Tuberculosis Diagnostics Market Definition And Segmentations
6.4 Market Segmentation By Test Type
- 6.4.1 Radiographic Test
- 6.4.2 Nucleic Acid Testing
- 6.4.3 Cytokine Detection Test
- 6.4.4 Drug Resistance Test
- 6.4.5 Skin Test/Mantoux Test (TST)
- 6.4.6 Blood Test/Serology Test
- 6.4.7 Smear Microscopy
- 6.4.8 Cultured-Based Tests
- 6.4.9 Other Test Types
6.5 Market Segmentation By Disease Stage
- 6.5.1 Latent Tuberculosis
- 6.5.2 Active Tuberculosis
6.6 Market Segmentation By End-User
- 6.6.1 Hospitals And Diagnostic Laboratories
- 6.6.2 Physician's Office Laboratories
- 6.6.3 Reference Laboratories
- 6.6.4 Academics And Research Facilities

7 Major Market Trends

7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics
7.2 New Product Innovations For Advanced Diagnostics Solutions
7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability
7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy
7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings
7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics
7.7 Technology Advancements To Transform The Landscape Of TB Detection
7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB

8 Tuberculosis Diagnostics Market - Macro-Economic Scenario

8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market
8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market
8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Tuberculosis Diagnostics Market Segmentation

10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tuberculosis Diagnostics Market, Regional and Country Analysis

11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis
13.6 UK Market
13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
14.6 Russia Market
14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Tuberculosis Diagnostics Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Tuberculosis Diagnostics Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Becton, Dickinson and Company
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Qiagen N.V.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 F. Hoffman-La Roche Ltd
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 BioMerieux SA
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Danaher Corporation (Cepheid, Inc.)
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Tuberculosis Diagnostics Market Other Major And Innovative Companies

20.1 Abbott Laboratories, Inc
- 20.1.1 Company Overview
- 20.1.2 Products And Services
20.2 Bio-Rad Laboratories, Inc
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Thermo Fisher Scientific, Inc
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 PerkinElmer, Inc
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 Bio-Techne Corporation
- 20.5.1 Company Overview
- 20.5.2 Products And Services
20.6 Hologic, Inc
- 20.6.1 Company Overview
- 20.6.2 Products And Services
20.7 Laboratory Corporation
- 20.7.1 Company Overview
- 20.7.2 Products And Services
20.8 Siemens Healthineers
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Akonni Biosystems Inc
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.10 Hain Lifescience GmbH
- 20.10.1 Company Overview
- 20.10.2 Products And Services
20.11 Creative Diagnostics
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 Lionex GmbH
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 Genedrive PLC
- 20.13.1 Company Overview
- 20.13.2 Products And Services
20.14 Mylab Discovery Solutions Pvt. Ltd
- 20.14.1 Company Overview
- 20.14.2 Products And Services
20.15 AdvaCare Pharma
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Molbio Diagnostics Acquired Prognosys Medical Systems
23.2 SD Biosensor Acquired Relab
23.3 Hologic Inc. Acquired Mobidiag Oy
23.4 PerkinElmer Acquired Oxford Immunotec
23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

24.1 Global Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Tuberculosis Diagnostics Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Tuberculosis Diagnostics Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer